More Press Releases

View Older Stories View Newer Stories

Mar 9, 2026 08:30AM Hakuhodo and Corundum Systems Biology to Co-Host Next Two Global Deep Tech VC Seminar Sessions
Mar 9, 2026 08:30AM Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
Mar 9, 2026 08:30AM Hims & Hers Announces Strategic Shift for US Weight Loss Business
Mar 9, 2026 08:30AM Five Point Strengthens San Mateo Midstream Platform to Support Next Phase of Growth and Value Creation
Mar 9, 2026 08:30AM Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology
Mar 9, 2026 08:30AM loanDepot Expands Market Presence With New Wholesale Lending Channel
Mar 9, 2026 08:30AM GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership
Mar 9, 2026 08:30AM Tenaya Therapeutics Presents Preclinical Data at MDA 2026 Highlighting TN-301’s Potential to Correct Skeletal and Cardiac Muscle Decline in Duchenne Muscular Dystrophy
Mar 9, 2026 08:30AM California Pizza Kitchen Doubles Down on Global Brand Growth with CPG Category Expansion and New International Markets
Mar 9, 2026 08:30AM Infigo Supports Think Patented’s Storefront Expansion and Operational Growth
Mar 9, 2026 08:30AM Dynasty Financial Partners Launches Partnership with Wealth.com’s Ester AI as a Service to Power Estate and Tax Planning
Mar 9, 2026 08:30AM Caris Life Sciences Launches a Novel Caris AI Insights Signature to Guide First-Line Therapy Selection and Treatment De-Escalation in Pancreatic Cancer
Mar 9, 2026 08:30AM CallMiner Delivers Breakthrough AI Advancements to Accelerate CX Automation
Mar 9, 2026 08:30AM Klotho Neurosciences Announces Rebranding to Greenland Mines Ltd and Change of Nasdaq Ticker Symbol to GRML Effective March 12, 2026
Mar 9, 2026 08:30AM Sallie Mae Announces $200 million Accelerated Share Repurchase
Mar 9, 2026 08:30AM PDS Health Enhances Marketing Performance with Marchex Conversation Intelligence
Mar 9, 2026 08:30AM MIPS and INOVA Collaborate to put Physical AI into the palm of Robotic hands with new Reference Platform
Mar 9, 2026 08:30AM Logistic Properties of the Americas Enters into Master Forward Purchase Agreement for Strategically Located Class A Industrial Real Estate Assets in Mexico
Mar 9, 2026 08:30AM Kawasaki Motors Manufacturing Corp. Wins Showcase Award for EVO Series Engines at Coolest Things Made in Missouri Event
Mar 9, 2026 08:30AM Moomoo Named Best Global Investment Platform by Sensor Tower, Capping a Year of Robust Growth and Innovation
Mar 9, 2026 08:30AM Empery Digital Announces Update on Share Repurchase Program
Mar 9, 2026 08:30AM Ampco-Pittsburgh Corporation Announces Significant Increase in Customer Orders
Mar 9, 2026 08:30AM Exchange Traded Concepts Announces Launch of BCGS ETF with Bancreek Capital Advisors
Mar 9, 2026 08:30AM Scrum Alliance® Announces Partnership With The Pathwayz Group
Mar 9, 2026 08:30AM YY Group Announces Preliminary Fiscal Year 2025 Financial Highlights
Mar 9, 2026 08:30AM Orion S.A. Earns Platinum Sustainability Rating From EcoVadis
Mar 9, 2026 08:30AM From Basement to Backyard: Brightspeed Delivers Whole Home WiFi, Optimized at Every Square Foot
Mar 9, 2026 08:30AM Morningstar Introduces AI Assistant Built into the Advisor Workflow
Mar 9, 2026 08:30AM Aon Announces First Stablecoin Insurance Premium Payment
Mar 9, 2026 08:30AM Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) ▼
Mar 9, 2026 08:30AM Aurora Mobile's EngageLab Launches OpenClaw Skills, Empowering AI Agents to Connect with the Real World
Mar 9, 2026 08:30AM JFB (NASDAQ: JFB) Announces XTEND Delivery of Tactical Drone Systems Under Defense Contract Valued at Up to $25 Million
Mar 9, 2026 08:30AM NovelMed Therapeutics Announces Regulatory Clearance for Subcutaneous Ruxoprubart and Reports Positive Phase II Intravenous Monotherapy Results in PNH
Mar 9, 2026 08:30AM UPDATE – Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses
Mar 9, 2026 08:30AM Jet.AI Inc. Reports Full Year 2025 Financial Results
Mar 9, 2026 08:30AM Founder Group Limited Secures US$4 million 25.4MW Utility-Scale Solar Contract under Malaysia’s CGPP Programme
Mar 9, 2026 08:30AM Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24
Mar 9, 2026 08:30AM Powell Max Limited Successfully Repositions for Its Next Phase of Growth
Mar 9, 2026 08:30AM Prairie Operating Co. Announces Participation in Upcoming Conference
Mar 9, 2026 08:30AM OZOP Energy Solutions, Inc. Highlights NBA Athlete Partnership Through Varon USA’s Joint Venture in Ballislife Drink
Mar 9, 2026 08:30AM GlobalFoundries Announces Availability of AutoPro150 eMRAM Technology on Enhanced FDX Platform for Advanced Automotive Applications
Mar 9, 2026 08:30AM First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleared by FDA for Advanced Soft-Tissue Diagnostics
Mar 9, 2026 08:30AM SRx Health Solutions Launches EventHorizonIQ Subscription for Individual and Institutional Traders
Mar 9, 2026 08:30AM SMX and LIQOS, by algo21, Partner to Build the World's First Tokenized Market Infrastructure for Verified Industrial Materials
Mar 9, 2026 08:30AM RevContent and Mula Announce Strategic Partnership to Launch Agentic Content Monetization OS, Bringing Article-Level Intelligence to Native Advertising
Mar 9, 2026 08:30AM Alico to Participate at 38th Annual Roth Conference
Mar 9, 2026 08:30AM Ainos Expands AI Nose Validation in Front-End Wafer Fabs with 200 Targeted Deployments in Q1 2026
Mar 9, 2026 08:30AM Eagle Nuclear Energy Corp. to Ring Nasdaq Opening Bell on March 11
Mar 9, 2026 08:30AM Biodexa Announces Support for Life’s a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients
Mar 9, 2026 08:30AM Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study
View Newer Stories View Older Stories